| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
UNC 0224
|
1197196-48-7 |
UNC 224
|
7-[3-(二甲基氨基)丙氧基]-2-(六氢-4-甲基-1H-1,4-二氮杂卓-1-基)-6-甲氧基-N-(1-甲基-4-哌啶基)-4-喹唑啉胺
|
C26H43N7O2 |
485.66532 | |
|
OF-1
|
919973-83-4 |
OF-1
|
|
C17H18BrN3O4S |
440.31152 | |
|
Endoxifen Hydrochloride
|
1032008-74-4 |
Z-因多昔芬盐酸盐
|
CS-1633;Z-因多昔芬盐酸盐
|
C25H28ClNO2 |
409.9542 | |
|
CL-387785
|
194423-06-8 |
CL-387785
|
CS-1630;EKI-785;WAY-EKI 785;CL387785;CL 387785;EKI785;WAY-EKI785;EKI 785;CL-387;785;N-[4-[(3-溴苯基)氨基]-6-喹唑啉基]-2-丁炔酰胺
|
C18H13BrN4O |
381.22602 | |
|
ONO-4059 analogue
|
1351635-67-0 |
ONO-459类似物
|
CS-1629;6-氨基-7,9-二氢-9-[(3S)-1-(1-氧代-2-丙烯-1-基)-3-哌啶基]-7-(4-苯氧基苯基)-8H-嘌呤-8-酮;ON 0459 ANALOG;ON-0459 ANALOG
|
C25H24N6O3 |
456.49646 | |
|
Marimastat
|
154039-60-8 |
马立马司他
|
马立马司他
|
C15H29N3O5 |
331.41 | |
|
E 64d
|
88321-09-9 |
阿洛司他丁
|
E-64d,蛋白酶抑制剂;阿洛司他丁;E-64-D(LOXISTATINE);E-64D蛋白酶抑制剂,阿洛司他丁;E-64D蛋白酶抑制剂
|
C17H30N2O5 |
342.43 | |
|
AS601245
|
345987-15-7 |
AS61245
|
AS601245.TFA盐;ALPHA-[2-[[2-(3-吡啶基)乙基]氨基]-4-嘧啶基]-2-苯并噻唑乙腈;CS-1619
|
C20H16N6S |
372.44624 | |
|
MSDC-0160
|
146062-49-9 |
MSDC-16
|
CAY10415;CAY-10415;CAY 10415;MSDC 0160;MSDC0160;MITOGLITAZONE;CAY10415;MSDC 0160;CS-1615;MSDC-0160
|
C19 H18 N2 O4 S |
370.43 | |
|
Cardiogenol C
|
671225-39-1 |
CARDIOGENOL C HCL
|
|
C13H16N4O2.ClH |
296.756 | |
|
SW033291
|
459147-39-8 |
SW33291
|
2-butylsulfinyl-4-phenyl-6-thiophen-2-ylthieno[5,4-b]pyridin-3-amine;SW033291;2-(butylsulfinyl)-4-phenyl-6-(thiophen-2-yl)thieno[2,3-b]pyridin-3-amine;2-(Butylsulfinyl)-4-phenyl-6-(2-thienyl)thieno[2,3-b]pyridin-3-amine;SW033291(SW-033291);4-phenyl-6-(thiophen-2-yl)-2-thioxo-1,2-
dihydropyridine-3-carbonitrile;Thieno[2,3-b]pyridin-3-amine, 2-(butylsulfinyl)-4-phenyl-6-(2-thienyl)-
|
|||
|
CEP-28122
|
1022958-60-6 |
CEP-28122
|
CEP 28122;CEP28122;CS-1605
|
C28H35ClN6O3 |
539.0689 | 200-258-5 |
|
AG-221-Enasidenib
|
1446502-11-9 |
恩西地平
|
AG221;AG 221;AG-211;CS-1590;恩西地平
|
C19H17F6N7O |
473.3749992 | |
|
ISX 9
|
832115-62-5 |
ISX 9
|
ISX-9;ISX 9;NEURONAL DIFFERENTIATION INDUCER III;N-环丙基-5-(噻吩-2-基)异恶唑-3-甲酰胺;CS-1582
|
C11H10N2O2S |
234.2743 | |
|
STF-31
|
724741-75-7 |
STF-31
|
4-[[[[4-叔丁基苯基]磺酰基]氨基]甲基]-N-3-吡啶基苯甲酰胺;STF31;STF 31;CS-1575
|
C23H25N3O3S |
423.5279 | 809-820-0 |
|
1-((2-Chlorophenyl)diphenylmethyl)-1H-pyrazole
|
289905-88-0 |
TRAM-34
|
TRAM34;TRAM 34;TRAM34;TRAM 34;TRIARYLMETHANE-34;CS-1574;1-[(2-氯苯基)二苯甲基]-1H-吡唑;1-((2-氯苯基)二苯基甲基)-1H-吡唑
|
C22H17ClN2 |
344.843 | |
|
Alda 1
|
349438-38-6 |
阿尔达1
|
ALDA1;ALDA 1;N-(苯并[D][1,3]二氧杂环戊烯-5-基甲基)-2,6-二氯苯甲酰胺;N-(1,3-苯并二氧杂环戊烯-5-基甲基)-2,6-二氯苯甲酰胺
|
C15H11Cl2NO3 |
324.15874 | |
|
CJ-023423
|
415903-37-6 |
GRAPIPRANT
|
CJ-023423;CJ 023423;CJ023423;CAS#415903-37-6;RQ-00000007;RQ 00000007;RQ00000007;AAT-007;AAT007;AAT 007;GRAPIPRANT;GRAPIPRANT;RQ-00000007;AAT-007;CS-1556
|
C26H29N5O3S |
491.60516 | |
|
SU5614
|
1055412-47-9 |
SU5614
|
SU 5614;SU-5614;(3Z(-5-氯-3-[(3,5-二甲基-1H-吡咯-2-基(亚甲基]-1,3-二氢-2H-吲哚-2-酮;CS-1552
|
C15H13ClN2O |
272.72952 | |
|
SU5607
|
186611-52-9 |
SU567
|
IC261>98%;3-(2,4,6-三甲氧基苯亚甲基)吲哚啉-2-酮;IC261;SU5607;IC 261;SU 5607;1,3-二氢-3-[(2,6-三甲氧基苯基)亚甲基]-2H-吲哚-2-酮
|
C18H17 N O4 |
311.335 |
药智官方微信
药智官方微博
